NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Mural Oncology plc (NASDAQ: MURA) to XOMA Royalty Corporation for $2.035 per share and, up to an additional $0.205 per share under certain conditions, is fair to Mural shareholders. Halper Sadeh encourages Mural shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or zhalper@ha
Related Questions
Is the proposed $2.035 per share price a fair valuation compared to Mural Oncology's current market price and intrinsic value?
How might the investigation and any related shareholder actions affect MURA's liquidity, short‑term volatility, and long‑term strategic outlook?
What are the potential upside or downside scenarios if the sale is deemed unfair and could lead to a legal challenge or renegotiation?